Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid-Derived Suppressor Cells”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Testing effectiveness (Phase 2)UnknownNCT03961698
What this trial is testing

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma

Who this might be right for
Breast CancerRenal Cell Carcinoma
Infinity Pharmaceuticals, Inc. 91
Very early researchStudy completedNCT03188276
What this trial is testing

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 52
Not applicableNot Yet RecruitingNCT06024226
What this trial is testing

Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC

Who this might be right for
Lung NeoplasmsMyeloid-Derived Suppressor CellsImmunosuppression
University Hospital, Bordeaux 10
Not applicableUnknownNCT01656824
What this trial is testing

Tissue Study of Bv8/PK-2 Inhibition in Human Cancer

Who this might be right for
Cancer
Rambam Health Care Campus 20
Early research (Phase 1)Active Not RecruitingNCT03161431
What this trial is testing

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Syntrix Biosystems, Inc. 77
Testing effectiveness (Phase 2)Study completedNCT02259231
What this trial is testing

RTA 408 Capsules in Patients With Melanoma - REVEAL

Who this might be right for
MelanomaUnresectable (Stage III) MelanomaMetastatic (Stage IV) Melanoma
Biogen 41
Not applicableLooking for participantsNCT05616130
What this trial is testing

Pathological Myeloid Activation After Sepsis and Trauma

Who this might be right for
Trauma InjurySepsisImmunosuppression+1 more
University of Florida 255
Not applicableEnded earlyNCT02903082
What this trial is testing

Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?

Who this might be right for
Severe SepsisInflammatory Response Syndrome, Systemic
University Hospital, Limoges 68
Not applicableNot Yet RecruitingNCT06764537
What this trial is testing

Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma

Who this might be right for
Glioblastoma
Central Hospital, Nancy, France 18
Testing effectiveness (Phase 2)Looking for participantsNCT05709574
What this trial is testing

Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
University of Arizona 10
Not applicableStudy completedNCT02868255
What this trial is testing

Myeloid Derived Suppressor Cells Control by Signal Regulatory Protein-alpha: Investigation in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Nantes University Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT03848182
What this trial is testing

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Albert Einstein College of Medicine 10
Early research (Phase 1)Study completedNCT04105335
What this trial is testing

MTL-CEBPA in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumours (TIMEPOINT)

Who this might be right for
Solid Tumor, Adult
Mina Alpha Limited 50
Not applicableLooking for participantsNCT05110937
What this trial is testing

Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis

Who this might be right for
SepsisTrauma Injury
University of Florida 450
Not applicableLooking for participantsNCT04022616
What this trial is testing

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center 99
Not applicableNot Yet RecruitingNCT07051928
What this trial is testing

Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.

Who this might be right for
Non Small Cell Lung Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 107
Testing effectiveness (Phase 2)Ended earlyNCT04209621
What this trial is testing

Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Small Lymphocytic Leukemia (SLL)Chronic Lymphocytic Leukemia (CLL)
National Heart, Lung, and Blood Institute (NHLBI) 3
Not applicableUnknownNCT04387682
What this trial is testing

Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients

Who this might be right for
Squamous Cell Carcinoma of the Oral Cavity
National Taiwan University Hospital 130
Early research (Phase 1)Study completedNCT02916979
What this trial is testing

Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG

Who this might be right for
Leukemia, LymphoidLeukemia, MyeloidMyelodysplastic Syndromes+4 more
Dartmouth-Hitchcock Medical Center 20
Early research (Phase 1)Study completedNCT03525925
What this trial is testing

Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center 16
Load More Results